Argenics on CNBC's "Fast Money"

CNBC's "Fast Money"July 29, 2026

Major Earnings After the Close… And the Fed Keeps Rates Unchanged 7/29/26

0:31
mid-roll
Melissa Lee
CNBC
July 29, 2026
Announcer-readDirect responseBaked-in adFood & Beverage
0:00 / 0:31
@ 28:31 in ep

Estimated current placement value

Low confidence
~$240range $36$1,700

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 2,000 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:31 · Announcer-read · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

With the Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe, self-injection is in your hands. It's your treatment routine. Use at the time and same day each week. Take the pre-filled syringe with you on vacation or have it handy for cozy staycations. For more information, visit livevividly.com. That's L-I-V-E-V-Y-V-I-D-L-Y.com. Brought to you by Argenics.

Auto-transcribed · verbatim audio matches · Report an error
Part of campaign

Argenics: Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled… · Jul 29–Aug 1, 2026

Vivgard Hytrulo, Efgard Tigamod Alpha, and Hyaluronidase QVFC pre-filled syringe

2 promos·2 shows

Argenics sponsor landing page on CNBC's "Fast Money"

Argenics sponsor landing page advertised on CNBC's "Fast Money"

Argenics landing page captured for its sponsorship on CNBC's "Fast Money".

livevividly.com/

Episode

CNBC's "Fast Money"
Major Earnings After the Close… And the Fed Keeps Rates Unchanged 7/29/26
Host: Melissa Lee
Publisher: CNBC